Drug application
HUMULIN 70/30 (INSULIN RECOMBINANT HUMAN, INSULIN SUSP ISOPHANE RECOMBINANT HUMAN)
Drugs@FDA BLA 019717 · LILLY
Key facts
| Drug name | HUMULIN 70/30 |
|---|---|
| Active ingredients | INSULIN RECOMBINANT HUMAN, INSULIN SUSP ISOPHANE RECOMBINANT HUMAN |
| Application type | BLA |
| Application number | 019717 |
| Company | LILLY |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | 30 UNITS/ML;70 UNITS/ML |
| Marketing status | Over-the-counter |
| Reference listed drug | No |
| Latest submission class | Type 5 - New Formulation or New Manufacturer |
| Latest submission status date | Apr 25, 1989 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- 10–99 Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: